4Aishan Shih,et al.Mechanisms for Radiation-induced Oral Mucositis and the Consequences[J].Cancer nursing,2003,26(3):222-229.
5Stacey M Fung,et al.Granulocyte macrophage-colony stimulating factor and roal mucositis[J].The Annals of Pharmacotherapy,2002,36:517-520.
6M Karthaus,et al.Prophylaxis and treatment of chemo-and radiotherapy-induced oral mucositis-are there new strategies[J].Bone Marrow Transplantation,1999,24:1 095-1 108.
7M.Hejna,et al.Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF[J].European Journal of Cancer,2001,37:1 994-2 002.
二级参考文献47
1Peterson DE. research advancce in oral mucositis. Curr Opin Oncol, 1999, 11(4) : 261 -266.
2Lockhart PB, Sonis ST. Relationship of oral complications to peripheral blood leukocyte and platelet counts in patients receiving cancer chemotherapy. Oral Surg Oral Med Oral Pathol, 1979, 48 (1): 21-28.
3Sonis ST. Mucositis as a biological process:a new hypothesis for the development of chemotherapy - induced sromatotoxicity. Oral Oncol, 1998, 34(1) : 39 -43.
4Sonis ST, Peterson RL, Edwards LJ, et al. Defining mechanisms of action of interleukin - 11 on the progression of radiation - induced oral mucositis in hamsters. Oral Oncol, 2000, 36(4) : 373 -381.
5Maj JG, Paris F, Haimovitz - Friedman A, et al. Microvascular function regulates intestinal crypt response to radiation. Cancer Res, 2003, 63:4338-4341.
6Sonis ST. Pathobiology of oral mucositis: novel insights and opportunities. J Support Oncol, 2007, 5(9) : 3 -11.
7Paris F, Fuks Z, Kang A, et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damageinmice. Science, 2001,293(5528) : 293 -297.
8Sonis ST. A biological approach to mueositis. J Support Oncol, 2004, 2(1): 21 -36.
9Biswa Mohan Biswal. current trends in the management of oral mucositis related to cancer treatment. Malaysian Journal of Medical Sciences, 2008, 15(3) : 4 -13.
10Redding SW. Cancer therapy - related oral mucositis..Journal of Dental Education, 2005, 69(8) : 919 -929.
2Davis M P, Walsh D. Epidemiology of cancer pain and factors in- fluencing poor pain control[J]. Am J Hosp Palliat Care,2004, 21(2): 137-142.
3NCCNJqCCN Guidelines,Adult Cancer Pain,Version 22012 [EB/OL]. (2012-09-26)[2013-10-20]http://wenku.baidu.com/view/3d3a- 9d61 led9ad51 f01df211.html.
4Biswa M B. Current trends in the management of oral mucositis related to cancer treatment. Malaysian loumal of Medical Science, 2008,15(3):4-13.
5Chi K FL Chen C H, Chart W K, et al. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil and leucovorin chemotherapy[J]. J Clin Oncol 1995, 13(10): 2620-2628.
6Wardley A M, Scarffe J H. Role of granulocyte-macrophage colony-stimulating factor in chemotherapy-induced oral mucositis[J]. J Clin Oncol, 1996, 14(5):1741-1743.
7Ibrahim E M, AI-Mulhim F A. Effect of granulocyte-macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutropenic cancerpadents[J]. Med Oncol 1997,14( 1 ): 47-51.
8Hepler C D, Strand L M. Opportunities and responsibilities in pharmaceutical care [J]. Am J Hosp Pharm, 1990,47(3):533-543.
9Kim HS,Kim EK,Jun HJ,et al.Noncutaneous malignant melanoma;aprognostic model from a retrospective multicenter study[J].BMCCancer,2010,10:167.
10Dawson CW,Port RJ,Young LS.The role of the EBV-encoded latentmembrane proteins LMP I and LMP2 in the pathogenesis of nasopharyn-geal carcinoma(NPC)[J].Semin Cancer Biol,2012,22(2):144-153.
